vs
太平洋生物科学（ASMB）与Castellum, Inc.（CTM）财务数据对比。点击上方公司名可切换其他公司
Castellum, Inc.的季度营收约是太平洋生物科学的1.2倍（$12.6M vs $10.8M），Castellum, Inc.净利率更高（-10.5% vs -85.2%，领先74.7%），太平洋生物科学同比增速更快（57.6% vs 21.9%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Castellum, Inc.是一家总部位于美国的网络安全与信息技术服务提供商，服务覆盖国防政府机构、公共部门及商业企业客户，提供威胁检测、数据保护、云安全及托管IT解决方案，助力客户防范网络风险、保护核心数字资产。
ASMB vs CTM — 直观对比
营收规模更大
CTM
是对方的1.2倍
$10.8M
营收增速更快
ASMB
高出35.7%
21.9%
净利率更高
CTM
高出74.7%
-85.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $12.6M |
| 净利润 | $-9.2M | $-1.3M |
| 毛利率 | — | 33.9% |
| 营业利润率 | -100.9% | -11.1% |
| 净利率 | -85.2% | -10.5% |
| 营收同比 | 57.6% | 21.9% |
| 净利润同比 | 4.3% | 51.8% |
| 每股收益（稀释后） | $-0.72 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBCTM
| Q4 25 | — | $12.6M | ||
| Q3 25 | $10.8M | $14.6M | ||
| Q2 25 | $9.6M | $14.0M | ||
| Q1 25 | $9.4M | $11.7M | ||
| Q4 24 | $7.4M | $10.3M | ||
| Q3 24 | $6.8M | $11.6M | ||
| Q2 24 | $8.5M | $11.5M | ||
| Q1 24 | $5.8M | $11.3M |
净利润ASMBCTM
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-9.2M | $415.4K | ||
| Q2 25 | $-10.2M | $-322.1K | ||
| Q1 25 | $-8.8M | $-1.2M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-9.6M | $-1.3M | ||
| Q2 24 | $-11.2M | $-1.8M | ||
| Q1 24 | $-9.1M | $-4.1M |
毛利率ASMBCTM
| Q4 25 | — | 33.9% | ||
| Q3 25 | — | 37.6% | ||
| Q2 25 | — | 36.1% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 40.0% | ||
| Q3 24 | — | 42.7% | ||
| Q2 24 | — | 40.6% | ||
| Q1 24 | — | 39.8% |
营业利润率ASMBCTM
| Q4 25 | — | -11.1% | ||
| Q3 25 | -100.9% | 3.0% | ||
| Q2 25 | -115.2% | -2.7% | ||
| Q1 25 | -105.5% | -12.7% | ||
| Q4 24 | — | -15.7% | ||
| Q3 24 | -160.1% | -11.9% | ||
| Q2 24 | -143.0% | -13.6% | ||
| Q1 24 | -185.5% | -23.6% |
净利率ASMBCTM
| Q4 25 | — | -10.5% | ||
| Q3 25 | -85.2% | 2.8% | ||
| Q2 25 | -105.9% | -2.3% | ||
| Q1 25 | -93.6% | -10.0% | ||
| Q4 24 | — | -26.6% | ||
| Q3 24 | -140.4% | -11.0% | ||
| Q2 24 | -130.7% | -16.0% | ||
| Q1 24 | -156.9% | -36.3% |
每股收益（稀释后）ASMBCTM
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.72 | $0.00 | ||
| Q2 25 | $-1.33 | $0.00 | ||
| Q1 25 | $-1.17 | $-0.01 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-1.51 | $-0.02 | ||
| Q2 24 | $-1.98 | $-0.03 | ||
| Q1 24 | $-1.66 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $35.8M |
| 总资产 | $240.0M | $41.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBCTM
| Q4 25 | — | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $18.7M | — |
总债务ASMBCTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $8.0M | ||
| Q3 24 | — | $8.3M | ||
| Q2 24 | — | $8.7M | ||
| Q1 24 | — | $9.0M |
股东权益ASMBCTM
| Q4 25 | — | $35.8M | ||
| Q3 25 | $182.7M | $36.7M | ||
| Q2 25 | $18.1M | $31.8M | ||
| Q1 25 | $27.1M | $26.1M | ||
| Q4 24 | $33.4M | $20.2M | ||
| Q3 24 | $26.0M | $12.0M | ||
| Q2 24 | $34.7M | $12.1M | ||
| Q1 24 | $32.6M | $12.8M |
总资产ASMBCTM
| Q4 25 | — | $41.9M | ||
| Q3 25 | $240.0M | $46.3M | ||
| Q2 25 | $80.8M | $43.4M | ||
| Q1 25 | $99.0M | $41.1M | ||
| Q4 24 | $119.2M | $37.8M | ||
| Q3 24 | $100.3M | $28.8M | ||
| Q2 24 | $115.3M | $29.5M | ||
| Q1 24 | $119.9M | $30.5M |
负债/权益比ASMBCTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.69× | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | 0.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-661.7K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBCTM
| Q4 25 | — | $-661.7K | ||
| Q3 25 | $-15.1M | $1.0M | ||
| Q2 25 | $-16.8M | $214.2K | ||
| Q1 25 | $-23.4M | $-2.5M | ||
| Q4 24 | $-51.1M | $-394.4K | ||
| Q3 24 | $-15.2M | $742.2K | ||
| Q2 24 | $-17.1M | $748.6K | ||
| Q1 24 | $-18.4M | $23.7K |
自由现金流ASMBCTM
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | $957.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | $738.9K | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBCTM
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | 6.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | -200.6% | — | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBCTM
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | 0.3% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率ASMBCTM
| Q4 25 | — | — | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
